Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Factors Predicting Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Lesion in Patients with Kawasaki Disease: Analysis of the Korean Nationwide Multicenter Survey from 2012 to 2014

  • Kim, Min Kyu (Department of Pediatrics, Good Moonwha Hospital) ;
  • Song, Min Seob (Department of Pediatrics, Inje University Haeundae Paik Hospital) ;
  • Kim, Gi Beom (Department of Pediatrics, Seoul National University Children's Hospital)
  • Received : 2017.06.27
  • Accepted : 2017.10.10
  • Published : 2018.01.31
⟨ Previous Next ⟩

Abstract

Background and Objectives: Approximately 10-15% of children with Kawasaki disease (KD) do not respond to initial intravenous immunoglobulin (IVIG) and have higher risk for coronary artery lesion (CAL). The aim of this study was to identify predictive factors from laboratory findings in patients who do not respond to IVIG treatment and develop CAL from KD. Methods: We retrospectively collected nationwide multicenter data from the Korean Society of Kawasaki Disease and included 5,151 patients with KD between 2012 and 2014 from 38 hospitals. Results: Among 5,151 patients with KD, 524 patients belonged to the IVIG-resistant group. The patients in the IVIG-resistant group had a significantly higher serum N-terminal pro-brain natriuretic peptide (NT-proBNP) level ($1,573.91{\pm}3,166.46$ vs. $940.62{\pm}2,326.10pg/mL$; p<0.001) and a higher percentage of polymorphonuclear neutrophils (PMNs) ($70.89{\pm}15.75%$ vs. $62.38{\pm}32.94%$; p<0.001). Multivariate logistic regression analyses revealed that significantly increased PMN, NT-proBNP, C-reactive protein (CRP), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) were the predictors of IVIG resistance (p<0.05). Multivariate logistic regression analyses also showed that only CRP was associated with the risk of CAL (p<0.01), while PMN, NT-proBNP, AST, and ALT were not. Conclusions: Elevated PMN, serum NT-proBNP, CRP, AST, and ALT levels are significantly associated with IVIG resistance in patients with KD. Moreover, serum CRP is significantly increased in patients with KD with CAL.

Keywords

References

  1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967;16:178-222.
  2. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110:2747-71. https://doi.org/10.1161/01.CIR.0000145143.19711.78
  3. Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 2005;47:232-4. https://doi.org/10.1111/j.1442-200x.2005.02033.x
  4. Giannouli G, Tzoumaka-Bakoula C, Kopsidas I, Papadogeorgou P, Chrousos GP, Michos A. Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period. Pediatr Cardiol 2013;34:1476-81. https://doi.org/10.1007/s00246-013-0673-9
  5. Furusho K, Kamiya T, Nakano H, et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984;2:1055-8.
  6. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986;315:341-7. https://doi.org/10.1056/NEJM198608073150601
  7. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991;324:1633-9. https://doi.org/10.1056/NEJM199106063242305
  8. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 1998;17:1144-8. https://doi.org/10.1097/00006454-199812000-00009
  9. Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C. Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 2003;24:145-8. https://doi.org/10.1007/s00246-002-0216-2
  10. Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 2000;105:E78. https://doi.org/10.1542/peds.105.6.e78
  11. Uehara R, Belay ED, Maddox RA, et al. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Pediatr Infect Dis J 2008;27:155-60.
  12. Cho KH, Kang SJ. Clinically useful predictors of resistance to intravenous immunoglobulin and prognosis of coronary artery lesions in patients with incomplete Kawasaki disease. Korean Circ J 2014;44:328-35. https://doi.org/10.4070/kcj.2014.44.5.328
  13. Baek JY, Song MS. Meta-analysis of factors predicting resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. Korean J Pediatr 2016;59:80-90. https://doi.org/10.3345/kjp.2016.59.2.80
  14. Kim BY, Kim D, Kim YH, et al. Non-responders to intravenous immunoglobulin and coronary artery dilatation in Kawasaki disease: predictive parameters in Korean children. Korean Circ J 2016;46:542-9. https://doi.org/10.4070/kcj.2016.46.4.542
  15. Yoshimura K, Kimata T, Mine K, Uchiyama T, Tsuji S, Kaneko K. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease. J Pediatr 2013;162:1205-9. https://doi.org/10.1016/j.jpeds.2012.11.026
  16. Research Committee on Kawasaki Disease (JP). Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Tokyo: Ministry of Health and Welfare; 1984.
  17. Rusconi PG, Ludwig DA, Ratnasamy C, et al. Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure. Am Heart J 2010;160:776-83. https://doi.org/10.1016/j.ahj.2010.07.012
  18. Ma KK, Ogawa T, de Bold AJ. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 2004;36:505-13. https://doi.org/10.1016/j.yjmcc.2004.01.001
  19. Nasser N, Bar-Oz B, Nir A. Natriuretic peptides and heart disease in infants and children. J Pediatr 2005;147:248-53. https://doi.org/10.1016/j.jpeds.2005.03.051
  20. Nir A, Nasser N. Clinical value of NT-ProBNP and BNP in pediatric cardiology. J Card Fail 2005;11:S76-80. https://doi.org/10.1016/j.cardfail.2005.04.009
  21. Dahdah N, Siles A, Fournier A, et al. Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr Cardiol 2009;30:810-7. https://doi.org/10.1007/s00246-009-9441-2
  22. Sato YZ, Molkara DP, Daniels LB, et al. Cardiovascular biomarkers in acute Kawasaki disease. Int J Cardiol 2013;164:58-63. https://doi.org/10.1016/j.ijcard.2011.06.065
  23. Shiraishi M, Fuse S, Mori T, et al. N-terminal pro-brain natriuretic Peptide as a useful diagnostic marker of acute Kawasaki disease in children. Circ J 2013;77:2097-101. https://doi.org/10.1253/circj.CJ-12-1281
  24. Kim SY, Han MY, Cha SH, Jeon YB. N-terminal pro-brain natriuretic peptide (NT proBNP) as a predictive indicator of initial intravenous immunoglobulin treatment failure in children with Kawasaki disease: a retrospective study. Pediatr Cardiol 2013;34:1837-43. https://doi.org/10.1007/s00246-013-0724-2
  25. Ha KS, Lee J, Jang GY, et al. Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease. Am J Cardiol 2015;116:301-6. https://doi.org/10.1016/j.amjcard.2015.04.021
  26. Kawamura Y, Takeshita S, Kanai T, Yoshida Y, Nonoyama S. The combined usefulness of the neutrophilto- lymphocyte and platelet-to-lymphocyte ratios in predicting intravenous immunoglobulin resistance with Kawasaki disease. J Pediatr 2016;178:281-284.e1. https://doi.org/10.1016/j.jpeds.2016.07.035
  27. Leliefeld PH, Wessels CM, Leenen LP, Koenderman L, Pillay J. The role of neutrophils in immune dysfunction during severe inflammation. Crit Care 2016;20:73. https://doi.org/10.1186/s13054-016-1250-4
  28. Takeshita S, Sekine I, Fujisawa T, Yoshioka S. Studies of peripheral blood toxic neutrophils as a predictor of coronary risk in Kawasaki disease--the pathogenetic role of hematopoietic colony-stimulating factors (GM-CSF, G-CSF). Acta Paediatr Jpn 1990;32:508-14. https://doi.org/10.1111/j.1442-200X.1990.tb00871.x

Cited by

  1. A Decade of NT-proBNP in Acute Kawasaki Disease, from Physiological Response to Clinical Relevance vol.5, pp.10, 2018, https://doi.org/10.3390/children5100141
  2. Biomarkers for Kawasaki Disease: Clinical Utility and the Challenges Ahead vol.7, pp.None, 2019, https://doi.org/10.3389/fped.2019.00242
  3. Risk Factors of Coronary Artery Abnormality in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis vol.7, pp.None, 2018, https://doi.org/10.3389/fped.2019.00374
  4. Predictive risk factors of coronary artery aneurysms in Kawasaki disease vol.62, pp.4, 2019, https://doi.org/10.3345/kjp.2019.00073
  5. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm vol.19, pp.2, 2018, https://doi.org/10.1007/s10238-018-00544-5
  6. Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population vol.8, pp.11, 2018, https://doi.org/10.1161/jaha.118.011319
  7. Evaluation of left ventricular function in immunoglobulin‐resistant children with Kawasaki disease: a two‐dimensional speckle tracking echocardiography study vol.42, pp.8, 2018, https://doi.org/10.1002/clc.23213
  8. Association between Alanine Aminotransferase/Aspartate Aminotransferase Ratio (AST/ALT Ratio) and Coronary Artery Injury in Children with Kawasaki Disease vol.2020, pp.None, 2018, https://doi.org/10.1155/2020/8743548
  9. Risk Factors of Intravenous Immunoglobulin Resistance in Children With Kawasaki Disease: A Meta-Analysis of Case-Control Studies vol.8, pp.None, 2020, https://doi.org/10.3389/fped.2020.00187
  10. Oxidised Low-Density Lipoprotein and Its Receptor-Mediated Endothelial Dysfunction Are Associated with Coronary Artery Lesions in Kawasaki Disease vol.13, pp.2, 2018, https://doi.org/10.1007/s12265-019-09908-y
  11. Clinical observation of noncoronary cardiac abnormalities in Chinese children with Kawasaki disease vol.50, pp.4, 2020, https://doi.org/10.1111/eci.13210
  12. Utility of color Doppler echocardiography combined with clinical markers in diagnosis and prediction of prognosis of coronary artery lesions in Kawasaki disease vol.19, pp.4, 2018, https://doi.org/10.3892/etm.2020.8519
  13. N-terminal pro-brain natriuretic peptide as a biomarker for predicting coronary artery lesion of Kawasaki disease vol.10, pp.None, 2020, https://doi.org/10.1038/s41598-020-62043-6
  14. Studying Clinical, Biologic and Echocardiography Criteria to Predict a Resistant Kawasaki Disease in Children vol.40, pp.8, 2018, https://doi.org/10.1097/inf.0000000000003144